Sepsis-Associated Encephalopathy and Blood-Brain Barrier Dysfunction

Area of Science:

• Neuroscience
• Immunology
• Critical Care Medicine

Background:

• Sepsis is a life-threatening infection response.
• Sepsis-associated encephalopathy (SAE) is a common neurological complication with high morbidity/mortality.
• SAE presents with varied neurological deficits, from confusion to coma.

Purpose of the Study:

• To review mediators of blood-brain barrier (BBB) dysfunction in sepsis.
• To highlight mechanisms contributing to sepsis-associated encephalopathy (SAE).
• To identify potential therapeutic targets for SAE.

Main Methods:

• Literature review of recent studies on SAE and BBB dysfunction.
• Analysis of mechanisms involving microglial activation and endothelial barrier function.
• Synthesis of information on neuroinflammation and BBB permeability in sepsis.

Main Results:

• Excessive microglial activation and impaired endothelial/BBB function are key SAE mechanisms.
• Systemic endotoxemia and cytokines activate brain cells and increase leukocyte recruitment.
• Neuroinflammation and BBB dysfunction worsen sepsis-induced brain injury.

Conclusions:

• Modulating microglial activation is a potential therapeutic strategy for SAE.
• Preventing endothelial cell dysfunction and BBB permeability can improve SAE outcomes.
• Targeting BBB dysfunction offers a promising avenue for managing sepsis-induced neurological complications.